Related Experiment Video
Updated: Aug 18, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Update on the use of stem cells for cardiac disease
J C Kovacic1, D W M Muller, R Harvey
1The Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.
Insights
Recent advances in stem cell biology offer new hope for treating cardiac disease. Stem cell therapies show promise in clinical trials for heart conditions like myocardial ischemia, potentially revolutionizing treatment.
Area of Science:
- Cardiology
- Regenerative Medicine
- Stem Cell Biology
Background:
- The adult mammalian heart was long considered to lack regenerative capacity.
- Recent discoveries have identified resident cardiac stem cells.
- This challenges the traditional view of cardiac repair.
Purpose of the Study:
- To review recent advances in stem cell biology and their application to cardiac disease.
- To evaluate the potential of stem cell-based therapies for myocardial ischemia and other cardiac disorders.
Main Methods:
- Review of current literature on cardiac stem cell research.
- Analysis of findings from preclinical animal models.
- Examination of results from early-phase human clinical trials.
Main Results:
- Stem cell-based approaches have demonstrated efficacy in animal models of cardiac disease.
- Phase I human clinical studies, despite limitations, show promising outcomes.
- Resident cardiac stem cells are now recognized, altering the understanding of cardiac regeneration.
Conclusions:
- Stem cell therapies represent a potential new therapeutic option for cardiac disorders.
- Further large-scale clinical trials (Phase II/III) are necessary to confirm efficacy.
- These therapies could significantly benefit patients with myocardial ischemia and related conditions.
Abstract:
Major advances have recently been made in our understanding of stem cell biology, and in the application of stem cells to treat cardiac disease. Resident cardiac stem cells have now been described and the long-accepted paradigm of the adult mammalian heart as an organ without regenerative capacity has been questioned. Various stem-cell-based approaches for ameliorating cardiac disease have been shown to be beneficial in animal models and are now being trialled in humans, with several phase I clinical studies already completed. Although these clinical studies lacked adequate placebo controls, they have consistently shown promising results. If confirmed by larger phase II/III trials, it is possible that within a few years a powerful new therapeutic option may be available for the burgeoning number of patients suffering from myocardial ischaemia and/or other cardiac disorders.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
Mesenchymal Stem Cells

